Valeo Pharma (TSX:VPH) ROE % Adjusted to Book Value : 0.00% (As of Apr. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma ROE % Adjusted to Book Value?

Valeo Pharma's ROE % for the quarter that ended in Apr. 2024 was 0.00%. Valeo Pharma's PB Ratio for the quarter that ended in Apr. 2024 was N/A. Valeo Pharma's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2024 was N/A.

Valeo Pharma ROE % Adjusted to Book Value Historical Data

The historical data trend for Valeo Pharma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma ROE % Adjusted to Book Value Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-19.48

-17.62

Valeo Pharma Quarterly Data
	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Valeo Pharma's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Valeo Pharma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Valeo Pharma's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Valeo Pharma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Valeo Pharma's ROE % Adjusted to Book Value falls into.

Valeo Pharma ROE % Adjusted to Book Value Calculation

Valeo Pharma's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Valeo Pharma's ROE % Adjusted to Book Value for the quarter that ended in Apr. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Valeo Pharma ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

VPHIF:USA VP2:Germany

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville

Senior Officer

Valeo Pharma Headlines

No Headlines